Big Move For NuCana plc
NuCana plc (NCNA:NASDAQ) jumped higher at $9.7, representing a gain of 181.2%. On Mon, Aug 19, 2024, NCNA:NASDAQ touched a New 2-Week High of $9.7. The stock appeared on our News Catalysts scanner on Fri, Aug 16, 2024 at 09:00 PM in the 'INVESTOR UPDATE' category. From Mon, Aug 05, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Wed, Mar 13, 2024 at $19.4 with a volume of 2M+.
About NuCana plc (NCNA:NASDAQ)
NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology.
Top 10 Gainers:
- Alzamend Neuro Inc. (ALZN:NASDAQ), 188.18%
- NuCana plc (NCNA:NASDAQ), 181.16%
- Unico American Corporation (UNAM:NASDAQ), 150%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 141.78%
- Sonder Holdings Inc. (SOND:NASDAQ), 130.53%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 128.64%
- SRAX, Inc. (SRAX:NASDAQ), 56%
- Telomir Pharmaceuticals Inc. (TELO:NASDAQ), 52.88%
- Electra Battery Materials Corporation (ELBM:NASDAQ), 50.24%
- Maxeon Solar Technologies Ltd. (MAXN:NASDAQ), 46.17%